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The poor translation efficiency of genome-length human rhinovirus RNA in vitro using HeLa cell extract-supplemented
rabbit reticulocyte lysate has hampered the study of rhinovirus IRES-mediated translation and polyprotein synthesis in a
cell-free system. In contrast, the efficient in vitro translation characteristics of poliovirus RNAs have ultimately allowed the
programming of cell-free coupled translation/replication extracts which are able to produce infectious poliovirus particles
in vitro. A possible explanation for the decreased burst size observed during the course of a rhinovirus infection, compared
to poliovirus infection, is reduced levels of polyprotein synthesis in vivo. In order to test this hypothesis and extend in vitro
translation/replication technology to the study of human rhinoviruses, a chimeric cDNA construct was engineered which
allowed the in vitro synthesis of T7 transcripts containing the intact poliovirus type 1 (PV1) 5* noncoding region (5* NCR)
and initiation codon upstream of the human rhinovirus 14 (HRV14) polyprotein-coding region and 3*-terminal sequences.
These chimeric RNAs translated efficiently in vitro and were used successfully to program a cell-free replication extract.
Unexpectedly, parental HRV14 RNAs also translated efficiently in the HeLa cell-free translation/replication extract but
replicated less efficiently than the chimera in vitro. The chimeric HRV14/PV1 RNAs were infectious and gave rise to a virus
with a growth phenotype similar to that of parental HRV14. Preliminary characterization of this chimeric virus suggests that
the biological properties characteristic of rhinovirus in vivo are determined primarily by the rhinovirus gene products.
Although the translation efficiency of the HRV14 5* NCR may be a limitation in rabbit reticulocyte lysate-based in vitro
translation extracts, it does not appear to be a major limiting determinant for growth of rhinovirus in vivo or replication in
the HeLa cell-free extract. q 1997 Academic Press
INTRODUCTION In this study, we report the translation and replication
of genome-length, in vitro-transcribed HRV14 RNAs in
The recent descriptions of virus production in cell-free
cell-free extracts prepared for coupled translation/repli-
extracts using in vitro-transcribed (or purified virion)
cation assays. The translation efficiency of HRV14 in
RNAs have brought an understanding of the picornavirus
these HeLa cell extracts was only slightly less efficient
life cycle at the biochemical level well within reach (Molla
(less than threefold) than that of poliovirus, in terms of
et al., 1991; Barton and Flanegan, 1993, 1995). These cell-
authentic, processed viral protein production. Program-
free extracts also allow the study of engineered genetic
ming the cell-free extract with a chimeric RNA containing
manipulations (using RNAs transcribed from mutated
the PV1 5* NCR upstream of the intact HRV14 coding
cDNA transcription vectors) in the absence of fitness
region and 3*-terminal sequences slightly enhanced
selection. Complete synthesis of infectious virus parti-
translation efficiency while markedly enhancing RNA rep-
cles in vitro has thus far only been described for the
lication efficiency in vitro. Additionally, the chimeric RNA
prototypic picornavirus, poliovirus type 1 (PV1), which
was infectious and gave rise to virus with a growth phe-
contains a genomic RNA that can be translated efficiently
notype similar to that of parental HRV14. The results of
and with high fidelity in reticulocyte lysate supplemented
a partial characterization of this chimeric virus in tissue
with HeLa cell extract (Brown and Ehrenfeld, 1979;
culture suggested that the inefficient growth properties
Dorner et al., 1984). A related picornavirus, human rhino-
of rhinovirus in cell culture, compared to poliovirus, are
virus 14 (HRV14), can be propagated in tissue culture
not a function of translation efficiency but are most likely
and can be manipulated as an infectious cDNA clone;
an inherent property of the rhinovirus gene products and/
however, attempts to translate genome-length HRV14
or gene regulation which determine fundamental virus
RNA in vitro have been largely unsuccessful (Borman and
growth characteristics such as packaging, burst size,
Jackson, 1992; Nguyen and Semler, unpublished results),
temperature optimum, and ultimately virulence.
possibly due to an inherent deficiency of the 629-nt
HRV14 5* noncoding region (5* NCR) (Callahan et al., MATERIALS AND METHODS
1985) not shared with the longer 743-nt 5* NCR of PV1
Construction of a chimeric HRV14 cDNA clone(Kitamura et al., 1981).
containing the PV1 5* NCR
The genome-length cDNA clone pT7-HRV14(ST) is1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (714) 824-8598. E-mail: blsemler@uci.edu. identical to pT7RV(F.L.) (Todd et al., 1995) with a region
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of the virus cDNA from NcoI (nt 2117) to NcoI (nt 4309) was radiolabeled by the random primer method (Fein-
berg and Vogelstein, 1983) using [a-32P]dATP and thereconstructed using an RT-PCR fragment amplified from
ATCC HRV14. The pT7-HRV14(ST) cDNA sequence dif- Klenow enzyme. The resulting DNA probe had a specific
activity of 108 CPM/ng.fers from the published HRV14 sequence (Callahan et
al., 1985) in at least two positions, resulting in a leu-to-
Northern blot analysishis change at amino acid 249 of VP1 (nt 3076) and an
arg-to-lys change at amino acid 11 of 2B (nt 3667). Virus
Total cytoplasmic RNA was prepared by the Nonidet-
resulting from transfection of RNA transcribed from pT7-
P40/SDS lysis method modified after Campos and Vil-
HRV14(ST) has superior growth characteristics (i.e.,
larreal (1982). RNA was extracted from HeLa R19 cells
larger plaque size) compared to virus derived from the
from dishes containing 2 1 105 cells at various times
pT7RV(F.L.) infectious clone. pT7-HRV14(ST) was di-
following an infection with PV5*-HRV14, HRV14, or PV1
gested with HinPII (HRV14 nt 633), repaired with Klenow,
at a multiplicity of infection (m.o.i.) of 10. Northern blot
and digested with NdeI (HRV14 nt 2987), and a 2354-
analysis was performed by resolving 2 mg of glyoxylated
bp fragment containing most of the P1-coding region of
RNA on a 1.2% agarose gel in 10 mM sodium phosphate
HRV14 was gel purified. This fragment was incubated in
buffer (McMaster and Carmichael, 1977) and transferring
the presence of T4 DNA ligase along with the large SphI
the RNA to GeneScreen membrane (Dupont). The blot
(4554)/NdeI (2055) fragment of pCITE-1 (Novagen), which
was then probed sequentially with 5*-end-labeled oligo-
contained the pUC18-derived ampicillin resistance gene
nucleotide probes RV2(0) (complementary to HRV14 nts
(no sequences corresponding to the encephalomyocardi-
905–925) and L164(0) (complementary to PV1 nts 633–
tis virus IRES were utilized). The resulting 4900-bp lin-
650). The blot was then probed with the random-primed
ear ligation product was gel purified, repaired with 1.8-kbp DNA fragment containing a portion of the hu-
Klenow, treated with alkaline phosphatase, and incu-
man b-actin cDNA sequence, described above.
bated together with the 810-bp pT7PV1 (Haller and
Semler, 1992) BsiHKAI fragment (containing the T7 pro- RNA transfection, virus propagation, plaque assays,
moter of the plasmid and the cDNA sequence of the PV1 and sequencing of virus RNAs
5* NCR), which had also been repaired with Klenow, in
In vitro transcription of full-length virus-specific RNAsthe presence of T4 DNA ligase. The resulting intermedi-
from cDNA constructs and DEAE-mediated RNA trans-ate plasmid contained the cDNA sequence of the PV1 5*
fection of R19 HeLa cells were performed as describedNCR and start codon linked to the P1 polyprotein coding
previously (Charini et al., 1991). Rhinovirus propagationsequence of HRV14. The intermediate plasmid was di-
in tissue culture cells and plaque assays have also beengested with SspI (pCITE-1 nt 183) and NdeI (pCITE-1 nt
described (Todd et al., 1995). In all cases, virus was2055, HRV14 nt 2987). The resulting 3600-bp fragment,
grown in MEM with 7% newborn calf serum and rhinovi-containing the chimeric viral cDNA sequence, was incu-
rus growth supplements [10 mM MgCl2 and 20 mMbated in the presence of T4 DNA ligase with the large
HEPES (N-2-hydroxyethylpiperazine-N*-2-ethanesulfonicfragment of pT7-HRV14(ST), which had been digested
acid) buffer (pH 7.4)]. Sequencing of virus RNAs fromwith MluI [former PvuII site (pGem1 nt 98)], repaired with
infected cells was performed as described by Charini etKlenow, and digested with NdeI (HRV14 nt 2987). Tran-
al. (1991), using the RNA isolation procedure modifiedscription of the resulting plasmid, pT7-PV5*-HRV14, with
after Campos and Villarreal (1982).T7 RNA polymerase resulted in a chimeric genome
length RNA containing the PV1 5* NCR with HRV14 down-
One-step growth cycle analysisstream sequences.
One-step growth analysis was performed on HeLa
5*-End-labeling of oligonucleotides and random (R19) cell monolayers in 6-well plates (16-mm dishes) at
primer-labeling of DNA fragments 337. Cells were infected with HRV14, PV5*-HRV14, or PV1
at an m.o.i. of 10, washed three times with PBS, and then
Approximately 60 pmol of oligonucleotide RV2(0) or
fed with MEM plus 7% newborn calf serum and rhinovirus
L164(0) was incubated in the presence of 50 mCi of 6000
growth supplements (see above). Cell monolayers were
Ci/mmol [g-32P]ATP and 60–100 U of T4 polynucleotide
harvested at various times after infection, subjected to
kinase in 50 ml for 30–45 min at 377. Unincorporated
five freeze–thaw cycles, and plaque assayed on HeLa
nucleotides were removed using a Sephadex G-50 spin
(R19) cell monolayers in 60-mm dishes.
column. The resulting 5*-end-labeled oligonucleotides
had a specific activity of 3 1 105 CPM/pmol. A plasmid Coupled in vitro translation/replication assays
containing the human b-actin cDNA sequence was ob-
tained from Denis Guttridge and Dennis Cunningham Extracts were prepared as described in Barton and
Flanegan (1995) with the following minor differences: (i)(Guttridge et al., 1993). Following digestion with EcoRI
and PstI, an 1.8-kbp DNA fragment (containing part of HeLa cells were resuspended in a volume equal to that of
the cell pellet using hypotonic buffer, and (ii) the initiationthe b-actin cDNA sequence) was gel purified and 50 ng
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FIG. 1. Schematic diagram of the pT7-PV5*-HRV14 chimeric cDNA construct. The region of the construct containing HRV14 cDNA sequences is
shown in white with the fully processed rhinovirus gene products indicated. The cDNA region corresponding to the PV1 5* NCR is shown in black.
The expanded diagram of the PV1 5* NCR indicates the RNA secondary structures involved in virus RNA replication or translation. Transcription of
the PstI-linearized plasmids with T7 RNA polymerase resulted in a chimeric, genome-length RNA containing the PV1 5* NCR with HRV14 downstream
sequences.
factor preparation used to supplement the translation/ A 2.8 1 108 PFU/ml second-passage (P2) stock of twice
plaque-purified virus was used for subsequent experi-replication reactions contained glycerol to a final concen-
tration of 10%. In addition, initial reactions (50 ml) were ments. Transfection-derived viruses from pT7-HRV14(ST)
(1.11 108 PFU/ml wild-type HRV14 P3 stock) and pT7PV1incubated at 307 to accommodate the HRV14 gene prod-
ucts. Replication complexes were resuspended in a 5-ml (7.0 1 1010 PFU/ml wild-type PV1 P3 stock) were used
for comparison.total volume in the presence of 25 mCi of 3000 mCi/mmol
[a-32P]CTP to label in vitro-synthesized RNAs. Coupled in We first examined the growth characteristics of the
chimeric virus compared to the parental viruses byvitro translation/replication reactions were programmed
with in vitro-transcribed RNA from EcoRI-linearized plas- plaque morphology in different cell lines at 33 and 377
[the preferred growth temperatures for human rhinovirusmid pT7PV1, PstI-linearized plasmid pT7-HRV14(ST), and
PstI-linearized plasmid pT7-PV5*-HRV14. (33–347) and poliovirus (377), respectively (Fields et al.,
1996)]. Plaques arising from the chimeric rhinovirus and
parental HRV14 were indistinguishable on HeLa (R19)RESULTS
monolayers incubated at 337 (Fig. 2). The plaques were
The construction of the chimeric virus T7-based cDNA heterogeneous with the larger plaques in the population
transcription vector is described in detail under Materials measuring 3.0 mm in diameter after 3 days and 4.5 mm
and Methods, and a schematic diagram of the cDNA is after 4 days. Poliovirus plaques measured 3.5 and 6.5
shown in Fig. 1. The RNA generated from in vitro tran- mm after 3 and 4 days, respectively (Fig. 2). Neither
scription of the resulting PstI-linearized plasmid, pT7- HRV14 or chimeric virus grew at 377. Poliovirus plaques
PV5*-HRV14, contains the intact PV1 5* NCR and transla- were considerably larger (4.5 mm, 2 days; 8.0 mm, 3
tion initiation codon upstream of the HRV14 polyprotein- days) at 377 compared to 337 (Fig. 2). All three viruses
coding region, 3* NCR, and poly(A) tract. The nucleotide were then tested in a human tracheal carcinoma cell line,
sequences flanking the translation initiation codon were HEp-2 (ATCC), to investigate the possibility that potential
identical to the respective wild-type (wt) parental viruses rhinovirus tissue-specific growth preferences may have
(Kitamura et al., 1981; Callahan et al., 1985). In vitro- been lost due to the presence of the PV1 5* NCR. Surpris-
transcribed RNA was transfected into HeLa (R19) cell ingly, neither HRV14 nor the chimera formed plaques in
monolayers in the presence of DEAE dextran (Charini et HEp-2 cells and poliovirus grew to a lower titer (0.6 log
al., 1991), and the transfected monolayers were incu- units) and produced smaller plaques [2.0 mm (3 days)
bated at 337. Complete lysis of monolayers under liquid and 6 mm (5 days) at 337, 4.5 mm (2 days) at 377] in HEp-
medium was obtained in less than 30 hr and plaques 2 cells compared to plaques obtained in HeLa (R19) cells
(data not shown).were harvested under semisolid medium after 3–4 days.
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FIG. 2. Plaque morphology of chimeric virus. Confluent 60-mm dishes infected with dilutions of HRV14, chimera, or PV1 virus stocks were overlaid
with semisolid medium and incubated at 33 or 377. The dishes were developed after 3 days at 337 or 2 days at 377 (top row) or after 4 days at 337
or 3 days at 377 (bottom row).
One-step growth analysis was performed on the chi- blot analysis using an antibody raised against the poliovi-
rus 2C (Hanecak et al., 1982), which cross-reacts withmeric virus, HRV14, and PV1 at 337 on HeLa (R19) mono-
layers. CPE were visible on monolayers infected with HRV14 2C (Emini et al., 1985), also demonstrated that
the levels of HRV14 2C present in cells 8 hr followingPV1 or the chimera earlier than on monolayers infected
with HRV14 (8–9 vs 10–11 hr). Additionally, complete infection with the chimera or parental HRV14 were com-
parable (data not shown).cell lysis occurred more rapidly with the chimera and
poliovirus (12 hr) compared to rhinovirus (18 hr). Nev- The detection of RNA replication by the chimeric virus,
ertheless, one-step growth analysis revealed that the vi-
rus replication kinetics were only marginally faster for
the chimera compared to those observed for HRV14, and
the burst sizes (PFU/cell) were virtually indistinguishable
(Fig. 3). The time course of poliovirus infection was
clearly more rapid and the burst size was more than one
log unit greater, consistent with previous results obtained
for transfection-derived poliovirus at 337 (Haller and
Semler, 1992).
In order to examine virus RNA replication kinetics more
directly, Northern blot analysis was performed using RNA
harvested from rhinovirus-, poliovirus-, or chimeric virus-
infected cells to assess the levels of accumulated viral
RNA during the course of infection. Total cytoplasmic
RNA was isolated every 2 hr for 12 hr following virus
infection, and a resulting Northern blot was probed se-
quentially with three different radiolabeled DNA probes
specific for (i) the PV1 5* NCR, (ii) the P1-coding region
of HRV14, or (iii) human b-actin (to verify uniform loading).
Note that a single probe could not be used to detect
RNA from all three viruses. The results shown in Fig. 4
FIG. 3. One-step growth analysis of the PV1/HRV14 chimera, HRV14,indicate that the levels of viral-specific RNA in the chime-
and PV1. Cell monolayers (incubated at 337) were harvested 4, 7.5, 10,ric virus-infected cells and HRV14-infected cells were
14, 16.5, and 18 hr (HRV14), 4, 7, 10, and 14 hr (chimera), or 3, 5.5, 8,
similar, while PV1-infected cells contain approximately 10, and 12.5 hr (PV1) following virus infection at an m.o.i. of 10. Plaque
twofold more genome-length RNAs which accumulate assays were developed after 3 days (PV1) or 4 days (HRV14, PV5*-
HRV14).more rapidly following infection (refer to Fig. 4B). Western
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FIG. 4. Viral RNA accumulation in infected cells. (A) Northern blot analysis of viral RNA synthesis. The 5*-end-labeled oligonucleotide probe
RV2(0) (complementary to HRV14 nts 905–925) was used to detect HRV14 RNA and chimeric virus RNA (top). The membrane was then stripped
and reprobed with 5*-end-labeled oligonucleotide probe L164(0) (complementary to PV1 nts 633–650) to detect chimeric virus RNA and PV1 RNA
(middle). Finally, the blot was stripped and probed with a random-primed 1.8-kbp DNA fragment containing a portion of the human b-actin cDNA
sequence (bottom). The kb sizes on the left side of the autoradiograms are derived from ethidium bromide staining of the gel containing the 0.24–
9.5 kb RNA ladder (Gibco-BRL), prior to transfer (marker lane). (B) Relative levels of viral RNA are shown vs time postinfection. The values were
obtained from densitometric scanning of each of the three autoradiograms in (A) using SigmaScan software. The values for HRV14 and the chimera
are based on probing with oligonucleotide RV2(0). The values for PV1 are calculated by correlating signals results obtained using oligonucleotide
L164(0) to those obtained using RV2(0) in detecting the chimeric virus RNA which is recognized by both probes. All values are normalized to the
b-actin control signal.
as well as its viability in tissue culture cells, indicated quence analysis to determine if the transfection-derived,
chimeric virus contained nucleotide sequence changesthat the chimeric RNA efficiently serves as a template
for the initiation of positive- and negative-strand RNA in the 5*-terminal cloverleaf region of the RNA genome
which were required to accommodate the rhinovirus rep-synthesis. Specifically, the 5*-terminal RNA cloverleaf
structure (the first 100 nts of the genomic positive- lication machinery. RNA isolated from cells infected with
the chimeric virus or poliovirus was sequenced in paral-strand RNA) is believed to be an important genetic deter-
minant for positive-strand RNA synthesis in picornavi- lel using a primer complementary to nts 93–113 of the
PV1 5* NCR. Both RNAs contained the wt PV1 sequenceruses. Biochemical and genetic data indicate that the
poliovirus 3CD protein, in concert with a cellular cofactor, (data not shown), indicating that the HRV14 replication
proteins, presumably in the form of a 3C-containing pre-binds specifically to the PV1 RNA cloverleaf structure
(Andino et al., 1990, 1993; Harris et al., 1994; Blair et cursor, were able to efficiently recognize the PV1 5*-
terminal cloverleaf structure. Interestingly, the data byal., 1996). Biochemical evidence also suggests that the
HRV14 3C protein interacts with the HRV14 cloverleaf Xiang et al. (1995) indicated that the converse recognition
may not occur in that the PV1 replication proteins cannotstructure (Leong et al., 1993), which is supported by crys-
tallographic data (Matthews et al., 1994). We subjected form a ribonucleoprotein complex with the HRV14 clover-
leaf structure.virus RNA isolated from HeLa (R19) cells infected with
the chimeric virus or poliovirus to partial nucleotide se- The in vitro properties of the chimeric rhino/poliovirus
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FIG. 5. Coupled in vitro translation/replication of genome-length RNAs. In vitro-transcribed PV1 RNA (lane 1), no RNA (lane 2), parental HRV14
RNA (lane 3), or chimeric PV1/HRV14 RNA (lane 4) was used to program HeLa cell-free translation/replication reactions (Barton and Flanegan,
1995) at 307. (A) A portion of each reaction was removed and incubated in the presence of [35S]methionine for 6 hr. Reactions were terminated by
the addition of Laemmli sample buffer and labeled proteins were analyzed on an SDS–12.5% polyacrylamide gel (Laemmli, 1970). (B) A second
portion of the translation reaction was removed after 6 hr and centrifuged at 15,000 g to isolate replication complexes. The pellets were resuspended
in HEPES buffer containing 25 mCi of 3000 mCi/mmol [a-32P]CTP and incubation was continued at 307 for 1 hr. The 32P-labeled products of the
reactions were resolved on a 1.1% agarose gel. A short exposure (3 hr) and a long exposure (12 hr) are shown. The remaining portion of each
reaction was incubated at 327 for an additional 14 hr to allow the assembly of virus particles. Plaque assays were performed in HeLa (R19)
monolayers to quantitate infectious virus particle formation (not shown).
RNAs, along with the parental HRV14 and PV1 RNAs, were (in the case of 2C) cross-reactivity with antibody raised
against poliovirus proteins.also examined using a HeLa cell-free coupled translation/
replication extract (Barton and Flanegan, 1993, 1995). Fig- A second portion of the translation reaction was centri-
fuged at 15,000 g and resuspended in reaction buffer withure 5A shows a polyacrylamide gel analysis of proteins
produced in HeLa cell extract incubated in the presence of 25 mCi of 3000 mCi/mmol [a-32P]CTP to label in vitro-
synthesized RNAs. The 32P-labeled products of the reac-of [35S]methionine at 307 which was programmed with in
vitro-transcribed PV1 RNA (lane 1), no RNA (lane 2), in tions were resolved on the 1.1% agarose gel shown in Fig.
5B. Two species of RNA are indicated in the figure: (i)vitro-transcribed parental HRV14 RNA (lane 3), or chimeric
PV1/HRV14 RNA (lane 4). Poliovirus RNAs translated effi- single-stranded, genome-length RNA (ssRNA) and (ii) puta-
tive replication intermediates in the synthesis of viral posi-ciently as expected. HRV14 RNA translated only slightly
less efficiently in Fig. 5A, although typically two- to threefold tive-strand RNAs, replicative form (RF) and replicative inter-
mediate (RI) (Bishop and Koch, 1967; Richards and Ehren-less efficiently (based on four experiments). The chimeric
rhinovirus RNA consistently translated with an efficiency feld, 1990). Based on densitometric scanning of the
radiolabeled ssRNA or RI/RF products generated in the inclose to that of poliovirus, and its polyprotein products
were processed efficiently into mature viral proteins in vitro translation/replication reaction detected on the auto-
radiogram (Fig. 5B), the chimeric RNA (lane 4) producedvitro. The identities of the rhinovirus proteins shown in
Fig. 5A are deduced from relative abundance compared ssRNA approximately two times more efficiently and RI/
RF RNA approximately six times more efficiently than theto other viral proteins, predicted molecular weights, and
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parental HRV14 RNA (lane 3). Reactions programmed with occurs at a step other than translation. As the levels of
RNA accumulated during an infection with HRV14 or theeither of these RNAs produced ssRNA and RI/RF RNA at
levels that appeared to be 10- to 20-fold lower than those chimera are only about twofold lower than those detected
during a poliovirus infection (Fig. 4), we postulate thatachieved by poliovirus RNA (lane 1).
The remaining portion of the coupled translation/repli- the primary impediment for rhinovirus production is likely
in packaging or capsid assembly. Perhaps a conse-cation reaction was assayed for virus yield by plaque
assay on HeLa (R19) monolayers. Virus yield from reac- quence of the structural variability maintained by the rhi-
noviruses, which results in over 100 distinct serotypestions programmed with in vitro-transcribed PV1 RNA gen-
erated31 106 PFU/ml, consistent with previous obser- (Fields et al., 1996), is inefficient packaging or assembly.
(ii) The rhinovirus gene products cannot function effi-vations (D. Barton and J. B. Flanegan, personal communi-
cation). Despite the demonstration of chimeric PV1/ ciently to generate virus at 377 even when translation is
driven by the poliovirus IRES (which normally functionsHRV14 RNA replication in vitro (as well as for parental
HRV14), no plaques were observed in repeated plaque at 377), indicating that protein processing, stability, and
function are likely perturbed at elevated temperatures.assays. In an effort to enhance RNA replication efficiency
in the cell-free extract and improve the chances of gener- This observation is consistent with evolutionary adapta-
tion to the nasopharyngeal cavity of humans and animals.ating infectious HRV14 or chimera virus particles in vitro,
coupled translation/replication reactions were pro- (iii) The 5*-terminal cloverleaf structure of PV1 RNA is
recognized by the HRV14 RNA replication initiation com-grammed with virion RNA (vRNA) isolated from HeLa
cell suspension cultures infected with HRV14, PV1, or plex and can functionally substitute for the HRV14 clover-
leaf structure to direct viral RNA replication, emphasizingchimeric virus. While poliovirus titers of 109 PFU/ml were
obtained in vitro by programming reactions with authen- a conservation of molecular genetic determinants for
RNA replication initiation. In fact, the chimeric RNA repli-tic PV1 vRNA, no plaques were obtained using HRV14
or chimera vRNA (data not shown). cated more efficiently than parental HRV14 RNA in vitro,
which we presume to be a result of the original optimiza-
tion of the HeLa cell extract preparations for poliovirusDISCUSSION
replication (Molla et al., 1991; Barton and Flanegan, 1993,
1995). The host cell requirements for rhinovirus positive-The in vivo and in vitro results we have described
with the parental HRV14 and PV5*-HRV14 chimera are strand RNA synthesis have not been well studied, but
may involve different host factors than are required forsignificant on two levels. First, the synthesis of parental
and chimeric rhinovirus RNA in a cell-free extract ex- poliovirus RNA replication. The observation that produc-
tion of RI/RF RNA was particularly enhanced in reactionspands upon the promise of being able to study the life
cycles of many medically and economically important programmed with chimeric RNA (compared to parental
HRV14 RNA; Fig. 5B, lanes 3 and 4) further suggests thathuman and animal viruses in vitro. Previous reports have
described the cell-free replication of only a single repre- positive-strand RNA synthesis may have been stimulated
by the presence of the PV1 cloverleaf structure. The lev-sentative member of the picornavirus family, poliovirus,
which has superb growth characteristics and contains els of synthesis of negative-strand RNAs would not be
predicted to change as a result of a 5*-terminal cloverleafan RNA which translates efficiently in vitro. Ideally, poorly
replicating members of the picornavirus family, such as substitution. Previous studies have shown that the HRV2
5* NCR cloverleaf structure (but not HRV14) can functionhepatitis A virus or perhaps members of other positive-
strand virus families, will benefit from cell-free transla- in the replication of a chimeric poliovirus RNA molecule,
demonstrating that the 5*-terminal genomic RNA se-tion/replication extracts to augment the use of tissue
culture. In this study, we have described the efficient quences and/or structures are not entirely interchange-
able (Xiang et al., 1995). Our results demonstrated thattranslation of wild-type rhinovirus genomic RNA, presum-
ably owing to the superior translation characteristics of while the poliovirus replication complex cannot recog-
nize (or utilize) the cloverleaf structure from HRV14, thethe HeLa cell extract preparations (Molla et al., 1991;
Barton and Flanegan, 1993, 1995). Furthermore, we have converse macromolecular recognition can occur. The
possibility also exists that additional replication determi-engineered a recombinant virus which retains the growth
characteristics of parental HRV14 in tissue culture while nants, which lie outside the cloverleaf structure, are re-
quired for efficient polymerase complex recognition toexploiting the slightly more efficient IRES-mediated trans-
lation properties of poliovirus. initiate positive-strand RNA synthesis (Borman et al.,
1994). Our complete 5* NCR substitution may preserveSecond, in terms of rhinovirus biology, several conclu-
sions can be drawn from the growth phenotype of the the presentation of these cis-acting signals, albeit to for-
eign replication machinery, while partial 5* NCR substitu-chimeric virus: (i) The slightly less efficient rhinovirus
IRES is probably not the primary reason for the reduced tions (i.e., only the cloverleaf structure) do not maintain
long-range interactions which normally occur in the 5*rhinovirus yield from infection of cells in culture, com-
pared to poliovirus. Our results suggest that the rate- NCR to direct efficient RNA replication. It has also been
reported that the PV3 genomic RNA 3* NCR can be func-limiting step for rhinovirus assembly during an infection
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Charini, W. A., Burns, C. C., Ehrenfeld, E., and Semler, B. L. (1991). Transtionally exchanged with the HRV14 or CB3 3* NCR (Rohll
rescue of a mutant poliovirus RNA polymerase function. J. Virol. 65,et al., 1995), further emphasizing the conserved nature
2655–2665.
of the functional RNA domains of picornavirus genomes. Dorner, A. J., Semler, B. L., Jackson, R. J., Hanecak, R., Duprey, E., and
Finally, the lack of production of infectious chimeric Wimmer, E. (1984). In vitro translation of poliovirus RNA: Utilization
of internal initiation sites in reticulocyte lysate. J. Virol. 50, 507–514.(or parental) rhinovirus particles in vitro is noteworthy. A
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